Difference between revisions of "Adenosarcoma of the uterus"

From Libre Pathology
Jump to navigation Jump to search
(split out)
(+infoboxes)
Line 1: Line 1:
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Image      = Uterine_adenosarcoma_-_high_mag.jpg
| Width      =
| Caption    = Uterine adenosarcoma. [[H&E stain]].
| Synonyms  =
| Micro      = "Malignant stroma" (stromal with nuclear pleomorphism - typically low grade), benign glands with an abnormal shape and "cambium layer" (increased cellularity around the epithelial elements)
| Subtypes  =
| LMDDx      = [[benign endometrial polyp]], [[uterine adenofibroma]], [[endometrial stromal sarcoma]]
| Stains    =
| IHC        = CD10 +ve, ER +ve, PR +ve
| EM        =
| Molecular  =
| IF        =
| Gross      =
| Grossing  =
| Site      = [[uterus]] - see ''[[uterine tumours]]''
| Assdx      =
| Syndromes  =
| Clinicalhx = typically 30-40 years old
| Signs      = vaginal bleeding, mass lesion
| Symptoms  =
| Prevalence = uncommon
| Bloodwork  =
| Rads      =
| Endoscopy  =
| Prognosis  =
| Other      =
| ClinDDx    = other causes of [[AUB]]
| Tx        = TAH-BSO
}}
'''Adenosarcoma of the uterus''' is an uncommon tumour that arises from the [[uterus]] with benign glands and [[malignant]] mesenchymal elements.  
'''Adenosarcoma of the uterus''' is an uncommon tumour that arises from the [[uterus]] with benign glands and [[malignant]] mesenchymal elements.  


Line 39: Line 70:
*[[Benign endometrial polyp]].
*[[Benign endometrial polyp]].
*[[Uterine adenofibroma]].
*[[Uterine adenofibroma]].
*[[Endometrial stromal sarcoma]].


===Images===
===Images===

Revision as of 02:52, 24 November 2014

Adenosarcoma of the uterus
Diagnosis in short

Uterine adenosarcoma. H&E stain.
LM "Malignant stroma" (stromal with nuclear pleomorphism - typically low grade), benign glands with an abnormal shape and "cambium layer" (increased cellularity around the epithelial elements)
LM DDx benign endometrial polyp, uterine adenofibroma, endometrial stromal sarcoma
IHC CD10 +ve, ER +ve, PR +ve
Site uterus - see uterine tumours
Clinical history typically 30-40 years old
Signs vaginal bleeding, mass lesion
Prevalence uncommon
Clin. DDx other causes of AUB
Treatment TAH-BSO

Adenosarcoma of the uterus is an uncommon tumour that arises from the uterus with benign glands and malignant mesenchymal elements.

General

Features:[1]

  • Uncommon.
  • May prolapse through cervical os and thus present as cervical polyp.
  • Most commonly uterine corpus, occasionally cervix and ovary, rarely in the vagina, fallopian tube, peritoneal surfaces, intestine.
  • Typically 30-40 years old.

Clinical:[2]

  • Most common presentations of Müllerian adenosarcoma (percentages based on series of 41 individuals[3]):
    • Vaginal bleeding ~ 70%.
    • Pelvic mass ~ 40%.
    • Uterine polyp ~ 30%.
  • Prognosis (based on series of ~500 individuals[4]):
    • Favourable outcome - most detected at an early stage.
      • ~80% five year survival for stage I tumours.
    • Outcome better than carcinosarcoma.

Treatment:

  • TAH-BSO.
    • Tumours are estrogen responsive.
  • Chemotherapy (platin-based).[3]

Microscopic

Features:[5][1]

  • "Malignant stroma" - key feature.
    • Stromal nuclear pleomorphism - usually low grade.
    • WHO criteria: 2+ mitoses / 10 HPF -- definition suffers from HPFitis.
      • Mitotic rate criteria often ignored as mitotically inactive tumours metastasize.[1]
  • Benign glands with an abnormal shape.
  • "Cambium layer" = increased cellularity around the epithelial elements.[1][6]

Notes:

DDx:

Images

  • Uterine adenosarcoma - low mag. (WC)

  • Uterine adenosarcoma - intermed. mag. (WC)

  • Uterine adenosarcoma - high mag. (WC)

IHC

  • CD10 +ve.[1]
  • ER +ve.
  • PR +ve.

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 McCluggage, WG. (Mar 2010). "Mullerian adenosarcoma of the female genital tract.". Adv Anat Pathol 17 (2): 122-9. doi:10.1097/PAP.0b013e3181cfe732. PMID 20179434.
  2. ↑ Abu, J.; Ireland, D.; Brown, L. (Apr 2007). "Adenosarcoma of an endometrial polyp in a 27-year-old nulligravida: a case report.". J Reprod Med 52 (4): 326-8. PMID 17506376.
  3. ↑ 3.0 3.1 Verschraegen, CF.; Vasuratna, A.; Edwards, C.; Freedman, R.; Kudelka, AP.; Tornos, C.; Kavanagh, JJ.. "Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience.". Oncol Rep 5 (4): 939-44. PMID 9625851.
  4. ↑ Arend, R.; Bagaria, M.; Lewin, SN.; Sun, X.; Deutsch, I.; Burke, WM.; Herzog, TJ.; Wright, JD. (Nov 2010). "Long-term outcome and natural history of uterine adenosarcomas.". Gynecol Oncol 119 (2): 305-8. doi:10.1016/j.ygyno.2010.07.001. PMID 20688363.
  5. ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 1089. ISBN 0-7216-0187-1.
  6. ↑ 6.0 6.1 URL: http://www.medilexicon.com/medicaldictionary.php?t=48297. Accessed on: 9 August 2011.
Retrieved from "https://librepathology.org/w/index.php?title=Adenosarcoma_of_the_uterus&oldid=35142"